RESUMEN
Dipeptidyl peptidase IV (DPP-IV) inhibitors improve glycemic control by prolonging the action of glucagon-like peptide-1 (GLP-1). In contrast to GLP-1 analogues, DPP-IV inhibitors are weight-neutral. DPP-IV cleavage of PYY and NPY gives rise to PYY3-36 and NPY3-36 which exert potent anorectic action by stimulating Y2 receptor (Y2R) function. This invites the possibility that DPP-IV inhibitors could be weight-neutral by preventing conversion of PYY/NPY to Y2R-selective peptide agonists. We therefore investigated whether co-administration of an Y2R-selective agonist could unmask potential weight lowering effects of the DDP-IV inhibitor linagliptin. Male diet-induced obese (DIO) mice received once daily subcutaneous treatment with linagliptin (3 mg/kg), a Y2R-selective PYY3-36 analogue (3 or 30 nmol/kg) or combination therapy for 14 days. While linagliptin promoted marginal weight loss without influencing food intake, the PYY3-36 analogue induced significant weight loss and transient suppression of food intake. Both compounds significantly improved oral glucose tolerance. Because combination treatment did not further improve weight loss and glucose tolerance in DIO mice, this suggests that potential negative modulatory effects of DPP-IV inhibitors on endogenous Y2R peptide agonist activity is likely insufficient to influence weight homeostasis. Weight-neutrality of DPP-IV inhibitors may therefore not be explained by counter-regulatory effects on PYY/NPY responses.
Asunto(s)
Inhibidores de la Dipeptidil-Peptidasa IV , Linagliptina/farmacología , Receptores de Neuropéptido Y , Animales , Masculino , Ratones , Ratones ObesosRESUMEN
Stimulation of the G protein coupled receptor GPR120 has been shown to have anti-inflammatory and insulin-sensitizing effects, to promote glucagon like peptide-1 (GLP-1) secretion, and to play a key role in sensing dietary fat and control energy balance. In a search for differentially expressed genes potentially involved in food intake and body-weight regulation we identified GPR120 to be differentially regulated in the intestine of selectively bred diet induced obese (DIO) and diet resistant (DR) rats. Subsequently we investigated the effect of GPR120 receptor stimulation with the long chain fatty acid alpha linolenic acid (ALA) on GLP-1 secretion in rats. Independent of diet (high or low fat), GPR120 expression showed a two-fold increase in the intestine of DIO compared to DR rats. In situ hybridization revealed a broad expression of GPR120 in the gut mucosa in both intestinal epithelial and endocrine cells. Using double in situ hybridization GPR120 mRNA did not appear to be enriched in preproglucagon expressing L-cells. In line with the anatomical data, ALA administration did not increase circulating GLP-1 levels. Our data shows a widespread expression of GPR120 in the gut epithelium and can not confirm a major role for GPR120 in the regulation of GLP-1 secretion. The broad expression of GPR120 in the gut epithelium supports reports indicating a putative role of GPR120 as a sensor of dietary fat.
Asunto(s)
Tracto Gastrointestinal/metabolismo , Péptido 1 Similar al Glucagón/metabolismo , Obesidad/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Administración Oral , Animales , Caprilatos/administración & dosificación , Caprilatos/farmacología , Dieta , Tracto Gastrointestinal/efectos de los fármacos , Péptido 1 Similar al Glucagón/sangre , Glucosa/administración & dosificación , Glucosa/farmacología , Insulina/sangre , Ácido Linoleico/administración & dosificación , Ácido Linoleico/farmacología , Masculino , Reacción en Cadena de la Polimerasa Multiplex , Obesidad/sangre , Proglucagón/metabolismo , Transporte de Proteínas/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Ratas WistarRESUMEN
The present study was initiated to improve our understanding of pancreatic beta-cell dynamics in male Zucker Diabetic Fatty (ZDF) rats and hence provide a framework for future diabetes studies in this animal model. Male ZDF rats from 6, 8, 10, 12, 14, 16, 20 and 26 weeks of age were subjected to an oral glucose tolerance test (OGTT). The animals were then euthanized and pancreases were removed for morphometric analyses of pancreatic beta-cell mass. As evident by a marked fourfold increase in insulin secretion, insulin resistance developed rapidly from 6 to 8 weeks of age. Simultaneously, the pancreatic beta-cell mass expanded from 6.17 ± 0.41 mg at 6 weeks of age, reaching a maximum of 16.5 ± 2.5 mg at 16 weeks of age, at which time pancreatic beta-cell mass gradually declined. The corresponding changes in glucose/insulin homeostasis were analysed using a standard insulin sensitivity index (ISI), an area under the curve (AUC) glucose-insulin index, or simple semi-fasted glucose levels. The study demonstrated that male ZDF rats underwent rapid changes in pancreatic beta-cell mass from the onset of insulin resistance to frank diabetes coupled directly to marked alterations in glucose/insulin homeostasis. The study underscores the need for a critical co-examination of glucose homeostatic parameters in studies investigating the effects of novel anti-diabetic compounds on pancreatic beta-cell mass in the male ZDF rat. A simple assessment of fasting glucose levels coupled with information about age can provide a correct indication of the actual pancreatic beta-cell mass and the physiological state of the animal.
Asunto(s)
Diabetes Mellitus Experimental/fisiopatología , Diabetes Mellitus Tipo 2/fisiopatología , Células Secretoras de Insulina/patología , Páncreas/citología , Páncreas/fisiopatología , Animales , Glucemia/análisis , Peso Corporal , Diabetes Mellitus Experimental/patología , Diabetes Mellitus Tipo 2/patología , Prueba de Tolerancia a la Glucosa , Homeostasis , Insulina/metabolismo , Resistencia a la Insulina , Células Secretoras de Insulina/metabolismo , Masculino , Ratas , Ratas ZuckerRESUMEN
In order to identify novel genes involved in appetite and body weight regulation we have developed a microarray based method suitable for detecting small changes in gene expression in discrete groups of hypothalamic neurons. The method is based on a combination of stereological sampling, laser capture microdissection (LCM), PCR based amplification (SuperAmp), and one-color cDNA microarray analysis. To validate the method we assessed and compared fasting induced changes in mRNA levels of Neuropeptide Y (NPY) and proopiomelanocortin (POMC) in the hypothalamic arcuate nucleus (ARC) of diet-induced obese rats using cDNA microarrays, quantitative PCR and in situ hybridization. All methods revealed statistically significant fasting-induced changes in NPY and POMC expression. An additional 3480 differentially expressed probes (fold change >1.22, t-test p=0.05) were identified in the microarray analysis. Our findings demonstrate a consistent gene expression pattern across three different gene expression detection methods and strongly suggest that LCM coupled microarray analysis combined with SuperAmp can be used as a semi-quantitative mRNA profiling tool. Importantly, the sensitivity of the method greatly improves the usefulness of the microarray technology for gene expression profiling in non-homogeneous tissues such as the brain.
Asunto(s)
Núcleo Arqueado del Hipotálamo/metabolismo , Perfilación de la Expresión Génica/métodos , Regulación de la Expresión Génica/fisiología , Análisis por Micromatrices/métodos , Microdisección/métodos , Transcripción Genética/fisiología , Análisis de Varianza , Animales , Grasas de la Dieta/efectos adversos , Ayuno/fisiología , Masculino , Neuropéptido Y/genética , Neuropéptido Y/metabolismo , Obesidad/etiología , Obesidad/metabolismo , Obesidad/patología , Proopiomelanocortina/genética , Proopiomelanocortina/metabolismo , ARN Mensajero/metabolismo , RatasRESUMEN
In a search for novel genes involved in the hypothalamic control of body energy homeostasis bioinformatic tools were applied. Analysis of the presence of structural features characteristic for secretory peptides was used as a first step in the identification of novel neuropeptides, and was followed by analysis of expression patterns. The gene product previously named TAFA5 was identified during this process. The overall mRNA expression pattern of TAFA5 was assessed using quantitative PCR on rat cDNA libraries. Furthermore, the brain mRNA and polypeptide expression patterns were examined in rats using in situ hybridization and immunohistochemistry. Our results substantiate previous findings that TAFA5 is mainly expressed in the central nervous system. Furthermore, we found TAFA5 mRNA to be highly expressed in the hypothalamic paraventricular nucleus (PVN) where it co-localized with vasopressin and oxytocin in magno- and parvocellular neurons. Immunohistochemical analysis revealed TAFA5 immunoreactivity in the PVN in accordance with the in situ hybridization data. Given the high levels of expression in the PVN, it was investigated whether TAFA5 mRNA levels were affected by fasting or dehydration. Interestingly, it was observed that TAFA5 mRNA was specifically down-regulated in the PVN following water deprivation. Based on our findings we suggest that TAFA5 may be involved in the regulation of fluid homeostasis.
Asunto(s)
Deshidratación/fisiopatología , Regulación hacia Abajo/fisiología , Expresión Génica/fisiología , Núcleo Hipotalámico Paraventricular/metabolismo , Péptidos/metabolismo , Análisis de Varianza , Animales , Biología Computacional , Citocinas , Masculino , Neuropéptidos/genética , Neuropéptidos/metabolismo , Oxitocina/metabolismo , Péptidos/genética , Conejos , Ratas , Ratas Sprague-Dawley , Factores de Tiempo , Vasopresinas/metabolismoRESUMEN
A group of neurons in the caudal nucleus of the solitary tract (NTS) processes preproglucagon to glucagon-like peptide 1 (GLP-1), GLP-2 and oxyntomodulin. Whereas the anorectic capacity of all three neuropeptides has been demonstrated, only relatively little is known of preproglucagon mRNA regulation in the brain stem. Using in situ hybridization and fluorescence immunohistochemistry, we examined hindbrain preproglucagon expression in lean and obese Zucker rats under different metabolic perturbations. First, the effect of an acute 48-h fast was examined in male Sprague-Dawley as well as in lean and obese Zucker rats. Whereas fasting had no effect on preproglucagon expression in either genotype, mRNA levels were strongly up regulated in obese Zucker rats. Using a direct immunostaining procedure and a monoclonal GLP-2 antibody, we found a doubling of the immunofluorescence signal emanating from the preproglucagon neurons in caudal brainstem suggesting that indeed the high mRNA levels observed using in situ hybridization histochemistry also reflect a higher translational activity. To investigate the effects of long-term body weight perturbations, lean and obese Zucker rats were either free-fed, voluntarily overfed (chocolate spread enriched chow) or food restricted for 35 days. Preproglucagon levels remained high in the obese Zucker rats irrespective of diet. Finally, in order to functionally validate the apparent hyperactivity in the preproglucagon system in the Zucker rat, we examined the effect of central GLP-1 receptor blockade. ICV administration of 20 microg of the GLP-1 receptor antagonist Des-His-Exendin-9-39 in the morning increased 4-h food intake in obese but not in lean Zucker rats, pointing to an increased activity in central preproglucagon containing pathways in leptin receptor deficient rats. Our data suggest that the preproglucagon neurons in the brainstem are influenced by leptin signaling and point to a role of preproglucagon neurons in the integration of metabolic signals that occurs in the nucleus of the solitary tract.
Asunto(s)
Regulación del Apetito/fisiología , Tronco Encefálico/metabolismo , Péptido 1 Similar al Glucagón/metabolismo , Obesidad/metabolismo , Proglucagón/biosíntesis , Núcleo Solitario/metabolismo , Animales , Tronco Encefálico/anatomía & histología , Tronco Encefálico/efectos de los fármacos , Restricción Calórica , Ritmo Circadiano/fisiología , Técnica del Anticuerpo Fluorescente , Privación de Alimentos/fisiología , Alimentos Formulados , Glucagón/análogos & derivados , Glucagón/farmacología , Receptor del Péptido 1 Similar al Glucagón , Hibridación in Situ , Leptina/metabolismo , Masculino , Obesidad/genética , Obesidad/fisiopatología , Proglucagón/genética , Biosíntesis de Proteínas/fisiología , ARN Mensajero/análisis , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Ratas Zucker , Receptores de Glucagón/antagonistas & inhibidores , Receptores de Glucagón/metabolismo , Receptores de Leptina/metabolismo , Núcleo Solitario/anatomía & histología , Núcleo Solitario/efectos de los fármacos , Regulación hacia Arriba/efectos de los fármacos , Regulación hacia Arriba/fisiologíaRESUMEN
Chronic treatment with compounds activating peroxisome proliferator-activated receptor (PPAR)gamma and -alpha influences body energy stores, but the underlying mechanisms are only partially known. In a chronic-dosing study, equiefficacious antihyperglycemic doses of the PPAR gamma agonist pioglitazone and PPAR alpha/gamma dual activator ragaglitazar were administered to obesity-prone male rats. The PPAR alpha agonist fenofibrate had no effect on insulin sensitivity. Pioglitazone transiently increased and fenofibrate transiently decreased food intake, whereas ragaglitazar had no impact on feeding. As a result, body adiposity increased in pioglitazone-treated rats and decreased in fenofibrate-treated rats. PPAR gamma compounds markedly increased feed efficiency, whereas PPAR alpha agonist treatment decreased feed efficiency. In fenofibrate-treated rats, plasma acetoacetate was significantly elevated. Plasma levels of this potentially anorectic ketone body were unaffected in pioglitazone- and ragaglitazar-treated rats. High-fat feeding markedly increased visceral fat pads, and this was prevented by pioglitazone and ragaglitazar treatment. Pioglitazone treatment enlarged subcutaneous adiposity in high-fat-fed rats. In conclusion, PPAR gamma activation increases both food intake and feed efficiency, resulting in net accumulation of subcutaneous body fat. The impact of PPAR gamma activation on feeding and feed efficiency appears to be partially independent because the PPAR alpha component of ragaglitazar completely counteracts the orexigenic actions of PPAR gamma activation without marked impact on feed efficiency.
Asunto(s)
Ingestión de Alimentos/fisiología , Metabolismo Energético/fisiología , Obesidad/fisiopatología , Receptores Citoplasmáticos y Nucleares/metabolismo , Tiazolidinedionas , Factores de Transcripción/metabolismo , Tejido Adiposo/fisiología , Animales , Biomarcadores , Glucemia , Ingestión de Alimentos/efectos de los fármacos , Metabolismo Energético/efectos de los fármacos , Fenofibrato/farmacología , Expresión Génica/efectos de los fármacos , Expresión Génica/fisiología , Prueba de Tolerancia a la Glucosa , Hemoglobina Glucada/análisis , Homeostasis/efectos de los fármacos , Homeostasis/fisiología , Hipoglucemiantes/farmacología , Hipolipemiantes/farmacología , Insulina/sangre , Lípidos/sangre , Hígado/fisiología , Masculino , Obesidad/metabolismo , Tamaño de los Órganos/fisiología , Oxazinas/farmacología , Fenilpropionatos/farmacología , Pioglitazona , Ratas , Ratas Mutantes , Tiazoles/farmacología , Aumento de Peso/fisiologíaRESUMEN
Cocaine-amphetamine-regulated transcript (CART) is one of the most abundantly expressed mRNAs in the rat hypothalamus. CART mRNA expression in the arcuate nucleus has been shown to be regulated by leptin, and CART peptides have been implicated in feeding behavior and in the regulation of the HPA-axis. To more fully understand the physiological regulation of CART gene expression, we have examined the effects of adrenalectomy and different types of glucocorticoid substitution (corticosterone and dexamethasone) on hypothalamic CART and POMC mRNA levels. In situ hybridization revealed a reduction in CART mRNA levels in both the hypothalamic paraventricular and arcuate nuclei in adrenalectomized rats, which was fully restored upon dexamethasone treatment but not by a subcutaneous 25% corticosterone pellet. Unlike CART mRNA levels hypothalamic POMC expression was unaltered by adrenenalectomy. The present results show that the CART gene is influenced by glucocorticoids, presumably via a GR dependent mechanism.